Continuing medical education

COVID-19 Infections and Hematologic Disturbances

This education will provide physicians with the resources necessary to discuss treatment options with patients, payers and administrators to ensure that each stakeholder understands the importance of those options for the management of patients with hematologic malignancies and COVID-19.

Intended Audience

• Primary Care, Oncology, Hematology

CME Forum 2020: 5th Annual Advancements in Cancer Management

CME Forum is an educational event designed to foster dialog between primary care providers (PCPs) and the oncology team, providing strategies that contribute to integrative care for patients with cancer. Recordings of presentations, case studies and Q & A sessions are available on demand or as live webinars to enhance clinician knowledge and competence. Click on the registration links to learn more about topics and faculty for each on demand event.

Molecular Tumor Board Series 2020

A multidisciplinary team discusses treatment options for cancer patients in a tumor board format based on data collected from patients, such as, genetic/genomic testing, pathology and radiological imaging. Cases discussed include: gallbladder carcinoma, triple negative breast cancer, endometrial cancer and adenocarcinoma of unknown primary.

Upon completion of this activity, participants will be able to:

• Describe the necessary components of an effective molecular tumor board
• Explain how to integrate genomic profiling into oncology treatment plans

Faculty:

• Jason Beland, MD (Cancer Treatment Centers of America)
• Arturo Loaiza-Bonilla, MD, MSEd, FACP (Cancer Treatment Centers of America)
• Pamela Crilley, DO (Cancer Treatment Centers of America)
• Maurie Markman, MD (Cancer Treatment Centers of America)
• Kimberly McGregor, MD (Foundation Medicine)
• Ankur Parikh, DO (Cancer Treatment Centers of America)
• Patricia Rich, MD (Cancer Treatment Centers of America)
• Julian Schink, MD (Cancer Treatment Centers of America)
• Bradford Tan, MD (Cancer Treatment Centers of America)

Multidisciplinary Management of Rectal Cancer in Young Adults: Facts and Controversies

This educational activity is designed to educate clinicians such as oncologists and gastroenterologists as well as physician-trainees, pharmacists, nurses and allied health professionals involved in the care and management of patients suffering from rectal cancer. In recent years, the average age of patients with rectal cancer has decreased. These younger patients require different treatment approaches. This activity is focused on sharing the various protocols for managing rectal cancer in young adults, focusing on how recommendations differ in a younger population, and emerging evidence of the effectiveness of various approaches in patients under 50.

Upon completion of this activity, participants will be able to:

• Explain the different approaches for managing rectal cancer in young adults
• Identify the appropriate approach for the treatment of rectal cancer in young adults

Faculty:

• Toufic Kachaamy, MD, FASGE (Cancer Treatment Centers of America)
• Madappa Kundranda, MD, PhD, FACP (Banner MD Anderson)
• David Etzioni, MS, MD (Mayo Clinic – Phoenix)